Answer
Burosumab must be discontinued if a serious hypersensitivity reaction occurs, and appropriate medical treatment should be initiated.
Sources for this answer
- Crysvita solution for subcutaneous injectionKyowa Kirin Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked